CCBR Brasil Centro de Analises e Pesquisas Clínicas LTDA

Rio de Janeiro, Rio de Janeiro 22271-100

0 studies enrolling now · 2 studies all time

What they study most

Axial Spondyloarthritis, Type 2 Diabetes Mellitus

Studies at this site

• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis — Completed
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed